The Prevalence of Wilson’s Disease:An Update
| Autor: | Ditte Emilie Munk, Peter Ott, Hendrik Vilstrup, Thomas Damgaard Sandahl, Tea Lund Laursen, Karl Heinz Weiss |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Population MEDLINE CERULOPLASMIN Disease DIAGNOSIS KOREAN POPULATION 03 medical and health sciences 0302 clinical medicine CARRIER FREQUENCY Hepatolenticular Degeneration Epidemiology Prevalence Medicine Humans education Allele frequency Selection (genetic algorithm) education.field_of_study Hepatology IDENTIFICATION business.industry MUTATIONS Incidence (epidemiology) CLINICAL PRESENTATION NATURAL-HISTORY Penetrance BLOOD SPOTS 030104 developmental biology ATP7B GENE 030211 gastroenterology & hepatology business Demography |
| Zdroj: | Sandahl, T D, Laursen, T L, Munk, D E, Vilstrup, H, Weiss, K H & Ott, P 2020, ' The Prevalence of Wilson’s Disease : An Update ', Hepatology, vol. 71, no. 2, pp. 722-732 . https://doi.org/10.1002/hep.30911 |
| Popis: | BACKGROUND AND AIMS: In 1984, Scheinberg and Sternlieb estimated the prevalence of Wilson disease to be 1:30,000 based on the limited available data. This suggested a large number of overlooked cases with potentially fatal consequences. The "Scheinberg-Sternlieb Estimate" is still widely used although more recent clinical and genetic studies of higher quality are now available. In the present study, we included these data to update the prevalence estimate.METHODS: A MEDLINE Ovid, Science Citation Index Expanded, and PubMed systematic search for all relevant studies on Wilson disease prevalence was conducted.RESULTS: In total, 59 studies (50 clinical and 9 population-based genetic) were included in the final analysis. We identified four recent clinical studies based on nationwide databases of high quality, providing prevalence estimates from 1:29,000 to 1:40,000. Higher frequency populations do exist due to frequent first cousin marriages and/or a higher mutation frequency. When calculating prevalence from the incidence related to number of births, estimates were 1:40,000-1:50,000. Clinical screening studies including examination for Kayser-Fleisher Rings or ceruloplasmin did not improve these estimates due to insufficient sample size or selection biases. Population-based genetic studies in US and UK populations were not in disagreement with the clinically-based estimates. At the same time studies from France and Sardinia suggested that the genetic prevalence may be 3-4 times higher than the clinical disease prevalence. This raises the question whether the penetrance is indeed 100% as generally assumed.CONCLUSION: The original prevalence estimate from 1984 of 1:30,000-1:50,000 still appears valid at least for USA, Europe and Asia. In some population-based studies, the genetic prevalence was 3-4 times higher than clinically based estimates. The question of penetrance needs further evaluation. This article is protected by copyright. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|